BioPharma

11 October, 2024 | Friday | News

Astellas Secures Exclusive Option for AVB-101 Gene Therapy in $2.18 Billion Deal with AviadoBio

Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development  AviadoBio receives $20 million equity investmen...

Lab

14 October, 2024 | Monday | News

Thermo Fisher Introduces Iliad (S)TEM: Advancing Atomic-Level Insights with EELS and NanoPulser Technology

Thermo Scientific Iliad integrates electron energy loss spectroscopy (EELS) and NanoPulser electrostatic beam blanker to improve insights at the atomic level Thermo Fisher Scientific Inc., the world leader in ...

BioTech

14 October, 2024 | Monday | News

Waters Corporation Launches Advanced LC-MS Tools to Accelerate RNA Therapeutic Development

Waters Corporation unveiled a new suite of liquid chromatography-mass spectrometry (LC-MS) grade reagents, enzymes, and software designed to simplify the analysis of large molecule RNA therapeutics. The compreh...

Contract Services

11 October, 2024 | Friday | News

Leading Drug Discovery CRO NovAliX Partners with Bruker to Transform Therapeutic Innovation

Bruker Acquires Minority Stake in NovAliX in Strategic Move Partnership Leverages Synergies Between Premium Drug Discovery CRO and High-Value Life Science Instrument Maker Focus on Enhancing Drug Discovery ...

Consumer Health

11 October, 2024 | Friday | News

CanSinoBIO Secures Over $17 Million Grant to Propel Polio Vaccine Trials in Indonesia and Advance Global Eradication Efforts

CanSino Biologics has announced a milestone in its fight against polio. The company has received an additional financial boost, securing a grant exceeding US$17 million to propel its recombinant poliovirus vacc...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close